Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01187
|
|||||
Drug Name |
Cupric sulfate
|
|||||
Synonyms |
7758-98-7; All Clear Root Destroyer; BCS copper fungicide; Blue copper (VAN); Blue stone; Bonide Root Destroyer; CUPRIC SULFATE; Copper II sulfate; Copper Sulfate Powder; Copper monosulfate; Copper sulfate; Copper sulfate (1:1); Copper sulfate (CuSO; Copper sulphate; Copper(2+) sulfate; Copper(II) sulfate; Copper(ii) sulfate, anhydrous; CuSO4; Cupric sulfate anhydrous; Cupric sulphate; Cupricsulfate; Delcup; Hylinec; Incracide 10A; Incracide E 51; Kupfersulfat [German]; Monocopper sulfate; Sulfuric acid copper(2+) salt (1:1); Trinagle
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Diabetes [ICD11: 5A10-5A14] | Preclinical | [1] | |||
Hyperlipoproteinemia [ICD11: 5C80] | Preclinical | [1] | ||||
Nocturia [ICD11: MF55] | Preclinical | [1] | ||||
Therapeutic Class |
Antiinfective Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
CuO4S
|
|||||
Canonical SMILES |
[O-]S(=O)(=O)[O-].[Cu+2]
|
|||||
InChI |
InChI=1S/Cu.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2
|
|||||
InChIKey |
ARUVKPQLZAKDPS-UHFFFAOYSA-L
|
|||||
CAS Number |
CAS 7758-98-7
|
|||||
Pharmaceutical Properties | Molecular Weight | 159.61 | Topological Polar Surface Area | 88.6 | ||
Heavy Atom Count | 6 | Rotatable Bond Count | 0 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
PubChem CID | ||||||
ChEBI ID |
CHEBI:23414
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | CTR1 | Transporter Info | High affinity copper uptake protein 1 | Substrate | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT00846144) The Reduction in Glucose Stimulated Insulin Secretion Induced by Cytokines May be Prevented by Copper Addition-Studies in Diabetic Patients | |||||
2 | Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci. 2010 Jul 14;30(28):9500-9. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.